NeueHealth, Inc. (NYSE:NEUE – Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 13,700 shares, a drop of 48.9% from the November 30th total of 26,800 shares. Approximately 0.5% of the company’s stock are sold short. Based on an average trading volume of 22,800 shares, the short-interest ratio is currently 0.6 days.
Insider Activity at NeueHealth
In related news, CEO George Lawrence Mikan III sold 16,803 shares of the stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $4.18, for a total value of $70,236.54. Following the sale, the chief executive officer now owns 83,029 shares in the company, valued at approximately $347,061.22. This represents a 16.83 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 64.30% of the stock is currently owned by insiders.
Hedge Funds Weigh In On NeueHealth
Institutional investors have recently modified their holdings of the company. Pathway Capital Management LP purchased a new stake in shares of NeueHealth in the second quarter worth approximately $61,000. Renaissance Technologies LLC bought a new stake in shares of NeueHealth in the 2nd quarter worth $312,000. Partners Group Holding AG bought a new stake in NeueHealth in the 3rd quarter worth about $463,000. Deer Management Co. LLC bought a new stake in NeueHealth in the 2nd quarter worth about $5,436,000. Finally, NEA Management Company LLC bought a new position in shares of NeueHealth during the 2nd quarter worth approximately $14,834,000. 63.88% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on NEUE
NeueHealth Stock Performance
Shares of NeueHealth stock traded up $0.07 during midday trading on Friday, hitting $7.34. 5,185 shares of the company traded hands, compared to its average volume of 21,309. The stock has a market cap of $60.81 million, a price-to-earnings ratio of -0.14 and a beta of 0.78. The firm’s fifty day moving average price is $5.14 and its 200-day moving average price is $5.26. NeueHealth has a 12 month low of $3.79 and a 12 month high of $16.59.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Recommended Stories
- Five stocks we like better than NeueHealth
- What is the Nasdaq? Complete Overview with History
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
- 3 Warren Buffett Stocks to Buy Now
- Power Play: Japan’s Top Auto Stocks Eye Historic Merger
- What is a Dividend King?
- S&P 500 Earnings Set to Shine: January’s Critical Market Test
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.